Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesISMRM 2024ISMRM: Advanced MRI techniques shed new light in multiple sclerosisSINGAPORE – Quantitative MRI techniques offer valuable insights into diverse pathological processes underlying multiple sclerosis (MS), with these techniques poised for clinical use, according to a leading expert.ISMRM 2024ISMRM: Does MRI have a role in the emergency department?ISMRM 2024ISMRM: AI model could reduce contrast agents in cardiac MRIISMRM 2024ISMRM: Tracking muscle fat with MRI could help reduce functional declineSponsor ContentWe care about what you think.